Stanley Nelson

Stanley Nelson, M.D.

A Short Biography:

Stanley F. Nelson, MD is a board certified pediatrician with specific experience with Duchenne muscular dystrophy and rare diseases.  He graduated from University of Michigan with a BS in Physics in 1982. Graduated from Duke University School of Medicine in 1987, and subsequently trained in Pediatrics and Pediatric Hematology-Oncology at UCSF.  He completed postdoctoral fellowship at Stanford University in 1993 before joining the faculty at UCLA. He is Professor of Human Genetics, Pediatrics, Neurology and Pathology and Laboratory Medicine at the David Geffen School of Medicine at UCLA where he has been faculty since 1993.  He is Co-Director of the Clinical Genomics Center, which develops and implements clinical genomic testing and established clinical exome sequencing at UCLA. He is a PI of the Undiagnosed Diseases Network at UCLA which performs discovery of new rare diseases.  He is Founder and Co-Director of the Center for Duchenne Muscular Dystrophy which is a multi-investigator program encompassing graduate and undergraduate education, basic and translational research, clinical care, and clinical trials for Duchenne at UCLA. Within the CDMD, he is the Director of the UCLA Certified Duchenne Care Center. His laboratory has published over 280 manuscripts including new analyses of the natural history of Duchenne muscular dystrophy and novel therapeutic strategies.  With the UCLA team, he provides care to approximately 200 Duchenne patients in clinic or in clinical trials and is expanding efforts to further improve rare disease diagnosis and translation to novel therapeutics.  


Work Titles:

  • UCLA Professor In-Residence
  • Human Genetics Director, DNA Microarray Technology
  • Co-Director, Center for Duchenne Muscular Dystrophy Education

Research Interest:

Duchenne muscular dystrophy

I lead the Center for Duchenne Muscular DYstrophy which coordinates activities to improve clinical care, clinical trials, education and research related to DMD and serve as a paradigm for progress in rare disease. Show Technical Interest

Detailed Biography:

Stanley F. Nelson, MD is Professor and Vice Chair of Human Genetics and Professor of Psychiatry within the David Geffen School of Medicine at UCLA where he has been on faculty since 1993. Prof. Nelson attended the University of Michigan and obtained a BS degree in Physics in 1982. He graduated from Duke University School of Medicine in 1987 and completed an ITT International Fellowship to Sweden in the Laboratory of George Klein. He was trained in Pediatrics and Pediatric Hematology-Oncology at UCSF School of Medicine, and subsequently trained as a postdoctoral fellow with Patrick Brown from 1990-1993 where he developed genomic mismatch scanning and initiated the lab development of DNA microarrays for genomic applications. At UCLA, Prof. Nelson has continued to be interested in technology development and application of genomics to cancer biology and common human diseases with active research areas in Autism, ADHD, vertigo and brain cancers. He developed and led the first genomics core on UCLA campus ( UCLA DNA Microarray Facility). He led the whole genome expression array analysis for the NIH Neuroscience Blueprint. With a team in Pathology and Pediatrics, he implemented whole exome sequencing for clinical purposes in 2011.  He formed the Center for Duchenne Muscular Dystrophy in 2007 with Drs. Miceli and Spencer that has grown into a unique center that provides coordinated patient care, access to clinical trials, translational and basic research, and educational opportunities on campus.  In 2014, he initiated with others, the Undiagnosed Diseases Network UCLA Clinical Site to improve diagnosis of individuals with difficult to diagnose genetic disorders.  His laboratory continues to develop and use genomic techology to pursue biological insights that lead to new therapeutic interventions in humans. 

Publications:

A selected list of publications: